Cartesian Therapeutics
RNAC
#7439
Rank
โ‚น27.42 B
Marketcap
โ‚น1,039
Share price
3.21%
Change (1 day)
-43.36%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -โ‚น6.47 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are โ‚น38.91 Million. , an increase over its 2023 earnings that were of -โ‚น20.08 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚น6.57 Billion-67.3%
2023 -โ‚น20.08 Billion-724%
2022 โ‚น3.21 B-649.67%
2021 -โ‚น0.59 Billion-89.78%
2020 -โ‚น5.73 Billion25.06%
2019 -โ‚น4.59 Billion-15.68%
2018 -โ‚น5.44 Billion-0.43%
2017 -โ‚น5.46 Billion83.41%
2016 -โ‚น2.98 Billion44.3%
2015 -โ‚น2.07 Billion